by Dr. Stephen Parker (Article selection and Commentary) on October 13, 2010
In trying to sort out what the statistics about the alleged effects of different drugs mean, this was one of the better articles… Treat Me? The crucial health stat you’ve never heard of. Slate Magazine By Darshak Sanghavi Sept. 26, 2006, If anything is supposed to be certain in medicine, it’s that people with high [...]
by Dr. Stephen Parker (Article selection and Commentary) on October 8, 2010
To Bristol Myers Squibb, the makers of Plavix: Perhaps your scare tactics will eventually backfire. Lots of folks out there have a very negative reaction to your gurney ads.. You’re making a major marketing mistake — Why not market an anti-anxiety pharmaceutical at the same time you are scaring people to death? (On the other [...]
by Dr. Stephen Parker (Article selection and Commentary) on October 8, 2010
Note that this study was funded by Bristol-Myers-Squibb, the makers of Plavix. Double-Dose Plavix Benefits Certain Patients, Study Finds And higher-dose aspirin is no more effective than low dose, researchers say Wednesday, September 1, 2010 (HealthDay News) – - More isn’t necessarily better when prescribing the two drugs commonly used to treat patients who are [...]
by Dr. Stephen Parker (Article selection and Commentary) on October 8, 2010
This is an article written by Merrill Goozner, an independent journalist. Sure makes the whole industry looks suspicious (no surprise, of course). Yes, why not aspirin? About Mr. Goozer: In April 2004, the University of California Press published his first book, “The $800 Million Pill: The Truth Behind the Cost of New Drugs,” an exposé [...]
by Dr. Stephen Parker (Article selection and Commentary) on October 7, 2010
The opinion stated in this blog is just that, an opinion. It should not be taken for medical advice. One of the most tasteless ads on TV – and that is a very, very low bar – is the Plavix ad where a gurney follows around a woman who has had a heart attack and [...]
by Dr. Stephen Parker (Article selection and Commentary) on October 6, 2010
The focus of this blog for the next week or so will be on Plavix. Please don’t mistake these articles for medical advice: they are provided so that you can make an informed decision about your heart. It is surprisingly difficult to find a good history of the development of Plavix. This information was fairly [...]